Company

Vecco is a business and technology solutions company focused on helping corporations gain significant and sustainable competitive advantage. Our suite of collaboration, real-time planning and process execution solutions help companies gain control and orchestrate their global supply chains achieving new levels of business transformation. Vecco was created by architects and professionals with hands on operation experience in real world Value Chain at companies including GE, Unilever, York International, Invensys, Schneider and Rockwell. It is robust, mature and a proven world-class business network collaboration solution suite for global businesses. Like yours!
Vecco is committed to helping you achieve:
- Transformative competitive advantage
- Shorter innovation cycles
- Lower risk from demand and supply volatility
- Increased revenue opportunities
- Lower cost to serve with increased perfect orders
- Sustained profitable growth
Our Values
- Vecco has a significant positive impact on clients and delivers more than what client’s expect
- Vecco delivers innovative, leading edge ideas, solutions and technology
Recent News
Benefits of Vecco Control Tower in Life Sciences – Part 4
Product Fulfillment Improvement in a Multi-tier Distribution Environment Scenario Name: Collaborative Fulfillment Improvement Industry Segment: Companies manufacturing make-to-stock products that are distributed through a multi-tier network. Capital intensive...
Benefits of Vecco Control Tower in Life Sciences – Part 3
New Customer Capture enabled by End-to-End Value Chain Collaboration Scenario Name: End to End Supply Chain Collaboration Department(s): Supply Chain, Procurement, Planning, IT, Account Managers User: Buyers, Supply Managers, Operations and Fulfillment Planners, Sales...
Benefits of Vecco Control Tower in Life Sciences – Part 2
International Licensee Royalty and Service Performance Compliance Scenario: A brand owner licenses production of certain of its major over the counter medicine brands to foreign manufacturers. It is to be paid royalties on the volume of medicine. However, the brand...